Brain Metastases

  • Tiago Costa de Pádua
  • Adrialdo José Santos
  • Hakaru Tadokoro
  • Ramon Andrade De MelloEmail author


Metastasis to the brain is the most feared complication of systemic cancer, and it is the most common intracranial tumor in adults, being symptomatic in more than two-thirds of patients, with similar manifestations observed in primary brain tumors. Any patients with a cancer diagnosis who present with neurologic symptoms must be examined carefully and imaging studies must be performed to exclude BMs. With treatment, survival improves, but it is still discouraging. The management of BMs is divided in two major goals: symptomatic control and specific cancer treatment. It is essential to have a multidisciplinary team, and the patient should be a part of the decision-making process.


Brain metastasis Supportive care Radiotherapy 


  1. 1.
    Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54CrossRefGoogle Scholar
  2. 2.
    De Angelis L, Posner JB (2009) Intracranial metastases. In: De Angelis L, Posner J (eds) Neurologic complications of câncer. Oxford University Press, New York, pp 141–193Google Scholar
  3. 3.
    Gavrilovic IT, Posner JB (2005) Brain metastases: epidemiology and pathophysiology. J Neuro-Oncol 75:5–14CrossRefGoogle Scholar
  4. 4.
    Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872CrossRefGoogle Scholar
  5. 5.
    Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359:2814–2823CrossRefGoogle Scholar
  6. 6.
    Nguyen TD, DeAngelis LM (2007) Brain metastases. Neurol Clin 25:1173–1192CrossRefGoogle Scholar
  7. 7.
    Guillamo JS, Emery E, Busson A, Lechapat-Zalcman E (2008) Traitement actuel des metastases cérébrales. Rev Neurol 64:560–568CrossRefGoogle Scholar
  8. 8.
    Lim LC, Rosenthal MA, Maartens N, Ryan G (2004) Management of brain metastases. Intern Med J 34:270–278CrossRefGoogle Scholar
  9. 9.
    Klos KJ, O’Neill BP (2004) Brain metastases. Neurologist 10:31–46CrossRefGoogle Scholar
  10. 10.
    Norden AD, Wen PY, Kesari S (2005) Brain metastases. Curr Opin Neurol 18:654–661PubMedGoogle Scholar
  11. 11.
    Davis PC, Hudgins PA, Peterman SB, Hoffman JC Jr (1991) Diagnosis of cerebral metastases: double-dose delayed CT vs contrast-enhanced MR imaging. AJNR Am J Neuroradiol 12(2):293–300PubMedGoogle Scholar
  12. 12.
    Schaefer PW, Budzik RF Jr, Gonzalez RG (1996) Imaging of cerebral metastases. Neurosurg Clin N Am 7(3):393–423CrossRefGoogle Scholar
  13. 13.
    Agazzi S, Pampallona S, Pica A, Vernet O, Regli L, Porchet F et al (2004) The origin of brain metastases in patients with a undiagnosed primary tumour. Acta Neurochir 146:153–157CrossRefGoogle Scholar
  14. 14.
    Polyzoidis KS, Miliaras G, Pavlidis N (2005) Brain metastasis of unknown primary: a diagnostic and therapeutic dilemma. Cancer Treat Rev 31:247–255CrossRefGoogle Scholar
  15. 15.
    Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive portioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751CrossRefGoogle Scholar
  16. 16.
    Soffietti R, Cornu P, Delattre JY, Grant R, Graus F, Grisold W et al (2006) EFNS Guidelines on diagnosis and treatment of brain metastases: report of a EFNS Task Force. Eur J Neurol 13:674–681CrossRefGoogle Scholar
  17. 17.
    Hempen C, Weiss E, Hess CF (2002) Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side effects? Support Care Cancer 10:322–328CrossRefGoogle Scholar
  18. 18.
    Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79(12):1489–1494CrossRefGoogle Scholar
  19. 19.
    Maschio M, Dinapoli L, Gomellini S, Ferraresi V, Sperati F, Vidiri A, Muti P, Jandolo B (2010) Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy. J Neuro-Oncol 98(1):109–116CrossRefGoogle Scholar
  20. 20.
    Gerber DE, Grossman SA, Streiff MB (2006) Management of venous thromboembolism in patients with primary and metastatic brain tumors. J Clin Oncol 24(8):1310–1318CrossRefGoogle Scholar
  21. 21.
    Schmidt F, Faul C, Dichgans J, Weller M (2002) Low molecular weight heparin for deep vein thrombosis in glioma patients. J Neurol 249(10):1409–1412CrossRefGoogle Scholar
  22. 22.
    Li J, Bentzen SM, Renschler M, Mehta MP (2008) Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis. Int J Radiat Oncol Biol Phys 71:64–70CrossRefGoogle Scholar
  23. 23.
    Vecht CJ, Haaxma-Reiche H, Noordijk EM, Padberg GW, Roormolen JH, Hoekstra FH, Tans JT, Lambooij N, Metsaars JA, Wattendorff AR (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery. Ann Neurol 33:583–590CrossRefGoogle Scholar
  24. 24.
    Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500CrossRefGoogle Scholar
  25. 25.
    Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22:3608–3617CrossRefGoogle Scholar
  26. 26.
    Shehata MK, Young B, Reid B, Patchell AR, St Clair W, Sims J, Sanders M, Meigooni A, Mohiuddin M, Regine WF (2004) Stereotatic radiosurgery of 468 brain metastases or= 2cm: implications for SRS dose and whole brain radiation therapy. Int J Radiat Oncol Biol Phys 59:87–93CrossRefGoogle Scholar
  27. 27.
    Jebjubsib MD, Haylock B, Shenoy A, Husband D, Javadpour M (2011) Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 47:649–655CrossRefGoogle Scholar
  28. 28.
    Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chapell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Metha MP (2002) A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 53:519–526CrossRefGoogle Scholar
  29. 29.
    Pinkham MB et al (2015) New Developments in intracranial stereoctactic Radiotherapy for metastases. Clin Oncol 27:316–323CrossRefGoogle Scholar
  30. 30.
    Lesser GJ (1996) Chemotherapy of cerebral metastases from solid tumors. Neurosurg Clin N Am 7(3):527–536CrossRefGoogle Scholar
  31. 31.
    Postmus PE, Smit EF (1999) Chemotherapy for brain metastases of lung cancer: a review. Ann Oncol 10(7):753–759CrossRefGoogle Scholar
  32. 32.
    Seoane J, De Mattos-Arruda L (2014) Brain metastasis: new opportunities to tackle therapeutic resistance. Mol Oncol 8:1120–1131CrossRefGoogle Scholar
  33. 33.
    Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjansen PE, Johnson BE, Ueoka H, Wagner H, Aisner J, Prophylactic Cranial Irradiation Overview Collaborative Group (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341(7):476–484CrossRefGoogle Scholar
  34. 34.
    Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ, Sculier JP (2001) Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 1:5CrossRefGoogle Scholar
  35. 35.
    Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E, Senan S, EORTC Radiation Oncology Group and Lung Cancer Group (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357(7):664–672CrossRefGoogle Scholar
  36. 36.
    Slotman BJ, Mauer ME, Bottomley A, Faivre-Finn C, Kramer GW, Rankin EM, Snee M, Hatton M, Postmus PE, Collette L, Senan S (2009) Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 27(1):78–84CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Tiago Costa de Pádua
    • 1
  • Adrialdo José Santos
    • 2
  • Hakaru Tadokoro
    • 3
  • Ramon Andrade De Mello
    • 4
    • 5
    Email author
  1. 1.Department of Medical OncologyFederal University of São Paulo, UNIFESPSão PauloBrazil
  2. 2.Neuro-Oncology, Hospital São PauloUniversidade Federal de São PauloSão PauloBrazil
  3. 3.Division of Medical Oncology, Escola Paulista de MedicinaFederal University of São PauloSão PauloBrazil
  4. 4.Division of Medical OncologyFederal University of São Paulo (UNIFESP) & Hospital Israelita Albert EinsteinSão PauloBrazil
  5. 5.Department of Biomedical Sciences and MedicineUniversity of AlgarveFaroPortugal

Personalised recommendations